| Year |
Title |
Altmetric |
| 2019
|
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease..
American Journal of Kidney Diseases.
73:218-229.
2019
|
|
| 2018
|
Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation..
Transplantation.
102:2080-2087.
2018
|
|
| 2018
|
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study..
Kidney International Reports.
3:1373-1384.
2018
|
|
| 2018
|
Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy..
Seminars in Nephrology.
38:461-476.
2018
|
|
| 2018
|
Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions..
Kidney International.
94:599-607.
2018
|
|
| 2018
|
Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors..
Annals of Surgery.
267:1161-1168.
2018
|
|
| 2018
|
Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-Year Single-Center Experience..
Annals of Surgery.
2018
|
|
| 2018
|
Evaluation of Potential Living Kidney Donors in the APOL1 Era..
Journal of the American Society of Nephrology.
29:1079-1081.
2018
|
|
| 2018
|
Life Expectancy for Patients From the Southeastern United States With IgA Nephropathy..
Kidney International Reports.
3:99-104.
2018
|
|
| 2018
|
Secondary IgA nephropathy..
Kidney International.
94:674-681.
2018
|
|
| 2018
|
Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy..
PLoS ONE.
13:e0190967.
2018
|
|
| 2017
|
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis..
Nephrology Dialysis Transplantation.
32:2079-2089.
2017
|
|
| 2017
|
Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage..
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.
37:1366-1373.
2017
|
|
| 2017
|
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy..
Kidney International Reports.
2:1194-1207.
2017
|
|
| 2017
|
Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index..
American Journal of Transplantation.
17:1540-1548.
2017
|
|
| 2017
|
Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation..
Journal of the American Society of Nephrology.
28:1943-1950.
2017
|
|
| 2017
|
A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction..
Journal of the American Society of Nephrology.
28:1306-1313.
2017
|
|
| 2017
|
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway..
PLoS Genetics.
13:e1006609.
2017
|
|
| 2017
|
Apolipoprotein L1 Gene Effects on Kidney Transplantation..
Seminars in Nephrology.
37:530-537.
2017
|
|
| 2017
|
Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy..
Kidney International.
91:235-243.
2017
|
|
| 2017
|
Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls..
International Journal of Nephrology.
2017:8210641.
2017
|
|
| 2016
|
Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy..
Journal of the American Society of Nephrology.
27:3278-3284.
2016
|
|
| 2016
|
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors..
Transplantation.
100:194-202.
2016
|
|
| 2016
|
Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes..
PLoS ONE.
11:e0152775.
2016
|
|
| 2016
|
Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?.
Disease Markers.
2016:7806438.
2016
|
|
| 2016
|
The MEST score provides earlier risk prediction in lgA nephropathy..
Kidney International.
89:167-175.
2016
|
|
| 2016
|
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy..
Frontiers in Immunology.
7:117.
2016
|
|
| 2016
|
Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study..
Disease Markers.
2016:3650909.
2016
|
|
| 2015
|
Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation..
Kidney International.
88:584-592.
2015
|
|
| 2015
|
Current Understanding of the Role of Complement in IgA Nephropathy..
Journal of the American Society of Nephrology.
26:1503-1512.
2015
|
|
| 2015
|
Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure..
American Journal of Transplantation.
15:1615-1622.
2015
|
|
| 2015
|
New Insights into the Pathogenesis of IgA Nephropathy..
Kidney Diseases.
1:8-18.
2015
|
|
| 2015
|
Should kidney donors be genotyped for APOL1 risk alleles?.
Kidney International.
87:671-673.
2015
|
|
| 2015
|
N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy..
Nephrology Dialysis Transplantation.
30:234-238.
2015
|
|
| 2014
|
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens..
Nature Genetics.
46:1187-1196.
2014
|
|
| 2014
|
Immune profile of IgA-dominant diffuse proliferative glomerulonephritis..
Clinical Kidney Journal.
7:479-483.
2014
|
|
| 2014
|
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes..
Journal of Biological Chemistry.
289:5330-5339.
2014
|
|
| 2014
|
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1..
Arthritis and Rheumatology.
66:390-396.
2014
|
|
| 2014
|
A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases..
PLoS ONE.
9:e98081.
2014
|
|
| 2014
|
Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease..
Journal of Immunology Research.
2014:197548.
2014
|
|
| 2014
|
Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy..
PLoS ONE.
9:e99026.
2014
|
|
| 2013
|
Biomarkers in IgA nephropathy: relationship to pathogenetic hits..
Expert Opinion on Medical Diagnostics.
7:615-627.
2013
|
|
| 2013
|
IgA nephropathy..
New England Journal of Medicine.
368:2402-2414.
2013
|
|
| 2013
|
Pathogenesis of immunoglobulin A nephropathy..
Current Opinion in Nephrology and Hypertension.
22:287-294.
2013
|
|
| 2013
|
IgA nephropathy: molecular mechanisms of the disease..
Annual Review of Pathology: Mechanisms of Disease.
8:217-240.
2013
|
|
| 2012
|
Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy.
Clinical Nephrology.
78:465-469.
2012
|
|
| 2012
|
Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy..
Clinical Nephrology.
78:465-469.
2012
|
|
| 2012
|
The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy..
Kidney International.
82:1284-1296.
2012
|
|
| 2012
|
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy..
Journal of the American Society of Nephrology.
23:1579-1587.
2012
|
|
| 2012
|
Reply to "genetic determinants of mycophenolate-related anemia and leukopenia after transplantation".
Transplantation.
93.
2012
|
|
| 2012
|
Glycosylation of IgA1 and pathogenesis of IgA nephropathy..
Springer Seminars in Immunopathology.
34:365-382.
2012
|
|
| 2012
|
Naturally occurring structural isomers in serum IgA1 o-glycosylation..
Journal of Proteome Research.
11:692-702.
2012
|
|
| 2012
|
Erratum: Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy (Journal of Clinical Investigation (2011) 121, 10 (3991-4002) DOI: 10.1172/JCI45563).
Journal of Clinical Investigation.
122:778.
2012
|
|
| 2012
|
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis..
PLoS Genetics.
8:e1002765.
2012
|
|
| 2012
|
In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells..
Results in Immunology.
2:166-172.
2012
|
|
| 2012
|
Serum galactose-deficient IgA1 level is not associated with proteinuria in children with IgA nephropathy..
International Journal of Nephrology.
2012:315467.
2012
|
|
| 2011
|
Membrane-assisted online renaturation for automated microfluidic lectin blotting..
Journal of the American Chemical Society.
133:19610-19613.
2011
|
|
| 2011
|
Sugars and alcohol: IgA-associated renal diseases in alcoholic cirrhosis..
Kidney International.
80:1252-1254.
2011
|
|
| 2011
|
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy..
Journal of the American Society of Nephrology.
22:1991-1996.
2011
|
|
| 2011
|
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells..
Nephrology Dialysis Transplantation.
26:3451-3457.
2011
|
|
| 2011
|
Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy..
Journal of Clinical Investigation.
121:3991-4002.
2011
|
|
| 2011
|
The pathophysiology of IgA nephropathy..
Journal of the American Society of Nephrology.
22:1795-1803.
2011
|
|
| 2011
|
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy..
Clinical Journal of the American Society of Nephrology.
6:1903-1911.
2011
|
|
| 2011
|
Validation of the Oxford classification of IgA nephropathy..
Kidney International.
80:310-317.
2011
|
|
| 2011
|
Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis..
Kidney International.
80:79-87.
2011
|
|
| 2011
|
Genome-wide association study identifies susceptibility loci for IgA nephropathy..
Nature Genetics.
43:321-327.
2011
|
|
| 2011
|
Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation..
Transplantation.
91:309-316.
2011
|
|
| 2011
|
Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium..
Transplantation.
91:300-308.
2011
|
|
| 2011
|
Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system..
Advances in Otorhinolaryngology.
72:60-63.
2011
|
|
| 2010
|
Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation..
Molecular and Cellular Proteomics.
9:2545-2557.
2010
|
|
| 2010
|
Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability..
Clinical Journal of the American Society of Nephrology.
5:2069-2074.
2010
|
|
| 2010
|
Genetic studies of IgA nephropathy: past, present, and future..
Pediatric Nephrology.
25:2257-2268.
2010
|
|
| 2010
|
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease..
Molecular and Cellular Proteomics.
9:2424-2437.
2010
|
|
| 2010
|
Recommendations for biomarker identification and qualification in clinical proteomics..
Science Translational Medicine.
2:46ps42.
2010
|
|
| 2010
|
Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study..
Biochemistry.
49:5671-5682.
2010
|
|
| 2010
|
Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1..
Nephrology Dialysis Transplantation.
25:1708-1713.
2010
|
|
| 2010
|
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults..
Kidney International.
77:921-927.
2010
|
|
| 2010
|
Tissue distribution and biological activities of immune complexes are determined by their size and composition..
Nephrology Dialysis Transplantation.
25:1007.
2010
|
|
| 2010
|
Familial IgA nephropathy in southeastern Kentucky..
Clinical Nephrology.
73:115-121.
2010
|
|
| 2010
|
Familial IgA nephropathy in southeastern Kentucky.
Clinical Nephrology.
73:115-121.
2010
|
|
| 2009
|
Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution..
Arthritis and Rheumatism.
60:2757-2766.
2009
|
|
| 2009
|
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility..
Kidney International.
76:546-556.
2009
|
|
| 2009
|
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification..
Kidney International.
76:534-545.
2009
|
|
| 2009
|
Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease..
PROTEOMICS - Clinical Applications.
3:1029-1043.
2009
|
|
| 2009
|
Secondary listing for deceased-donor kidney transplantation does not increase likelihood of engraftment at a large transplant center..
American Journal of Transplantation.
9:1671-1673.
2009
|
|
| 2009
|
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity..
Journal of Clinical Investigation.
119:1668-1677.
2009
|
|
| 2009
|
Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate..
American Journal of Transplantation.
9:1243-1248.
2009
|
|
| 2009
|
Application of Proteomic Analysis to Renal Disease in the Clinic..
PROTEOMICS - Clinical Applications.
3:1023-1028.
2009
|
|
| 2008
|
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics..
PROTEOMICS - Clinical Applications.
2:964.
2008
|
|
| 2008
|
Urinary proteomics in diabetes and CKD..
Journal of the American Society of Nephrology.
19:1283-1290.
2008
|
|
| 2008
|
Systolic dysfunction portends increased mortality among those waiting for renal transplant..
Journal of the American Society of Nephrology.
19:1191-1196.
2008
|
|
| 2008
|
Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy..
Journal of the American Society of Nephrology.
19:1008-1014.
2008
|
|
| 2008
|
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1..
Journal of Clinical Investigation.
118:629-639.
2008
|
|
| 2008
|
IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy..
Seminars in Nephrology.
28:78-87.
2008
|
|
| 2008
|
Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy..
Kidney and Blood Pressure Research.
31:29-37.
2008
|
|
| 2007
|
Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases..
ELECTROPHORESIS.
28:4469-4483.
2007
|
|
| 2007
|
Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura..
Pediatric Nephrology.
22:2067-2072.
2007
|
|
| 2007
|
Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy..
Fresenius' Journal of Analytical Chemistry.
389:1397-1407.
2007
|
|
| 2007
|
Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases..
World Journal of Urology.
25:467-476.
2007
|
|
| 2007
|
High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine..
PROTEOMICS - Clinical Applications.
1:792.
2007
|
|
| 2007
|
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels..
Kidney International.
71:1148-1154.
2007
|
|
| 2007
|
The genetics of IgA nephropathy..
Nature Clinical Practice Nephrology.
3:325-338.
2007
|
|
| 2007
|
Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells..
Journal of Molecular Biology.
369:69-78.
2007
|
|
| 2007
|
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins..
Molecular Immunology.
44:2598-2604.
2007
|
|
| 2007
|
Clinical proteomics: A need to define the field and to begin to set adequate standards..
PROTEOMICS - Clinical Applications.
1:148-156.
2007
|
|
| 2007
|
IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells..
Contributions to Nephrology.
157:134-138.
2007
|
|
| 2007
|
IgA nephropathy: a clinical overview..
Contributions to Nephrology.
157:19-26.
2007
|
|
| 2007
|
IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1..
Contributions to Nephrology.
157:129-133.
2007
|
|
| 2007
|
IgA nephropathy: current views of immune complex formation..
Contributions to Nephrology.
157:56-63.
2007
|
|
| 2006
|
IgA-containing immune complexes in the urine of IgA nephropathy patients..
Nephrology Dialysis Transplantation.
21:2478-2484.
2006
|
|
| 2006
|
Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation..
Annals of Internal Medicine.
144:735-741.
2006
|
|
| 2006
|
Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group..
Clinical Journal of the American Society of Nephrology.
1:467-474.
2006
|
|
| 2005
|
Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil..
Nephrology Dialysis Transplantation.
20:1214-1221.
2005
|
|
| 2005
|
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells..
Kidney International.
67:504-513.
2005
|
|
| 2004
|
Incidence of hip osteonecrosis among renal transplantation recipients: a prospective study..
Clinical Radiology.
59:431-438.
2004
|
|
| 2004
|
Angiotensin II receptor type 1 expression in erythroid progenitors: Implications for the pathogenesis of postrenal transplant erythrocytosis..
Seminars in Nephrology.
24:120-130.
2004
|
|
| 2004
|
IgA nephropathy: an update..
Current Opinion in Nephrology and Hypertension.
13:171-179.
2004
|
|
| 2003
|
Bone mineral density changes within six months of renal transplantation.
Transplantation.
75:49-54.
2003
|
|
| 2003
|
Bone mineral density changes within six months of renal transplantation..
Transplantation.
75:49-54.
2003
|
|
| 2002
|
Interactions of human mesangial cells with IgA and IgA-containing immune complexes..
Kidney International.
62:465-475.
2002
|
|
| 2001
|
Progress in molecular and genetic studies of IgA nephropathy..
Journal of Clinical Immunology.
21:310-327.
2001
|
|
| 2001
|
Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up..
Transplantation.
71:1681-1683.
2001
|
|
| 2000
|
Focal posttransplantation lymphoproliferative disorder at the renal allograft hilum..
American Journal of Roentgenology.
175:1417-1422.
2000
|
|
| 2000
|
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23..
Nature Genetics.
26:354-357.
2000
|
|
| 2000
|
Treatment of IgA nephropathy..
Seminars in Nephrology.
20:277-285.
2000
|
|
| 2000
|
Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation..
Transplantation.
69:809-814.
2000
|
|
| 2000
|
IgA1 glycosylation and the pathogenesis of IgA nephropathy..
American Journal of Kidney Diseases.
35:551-556.
2000
|
|
| 1999
|
Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group..
Transplantation.
68:1526-1532.
1999
|
|
| 1999
|
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies..
Journal of Clinical Investigation.
104:73-81.
1999
|
|
| 1999
|
Expression of stem cell factor by osteoblasts in normal and hyperparathyroid bone: relation to ectopic mast cell differentiation..
Virchows Archiv.
435:50-57.
1999
|
|
| 1999
|
Parathyroid hormone-regulated production of stem cell factor in human osteoblasts and osteoblast-like cells..
Biochemical and Biophysical Research Communications.
255:778-784.
1999
|
|
| 1999
|
Treatment of immunoglobulin A nephropathy..
Annales de Medecine Interne.
150:127-136.
1999
|
|
| 1999
|
Progress in the pathogenesis of IgA nephropathy..
Advances in Nephrology.
29:53-72.
1999
|
|
| 1998
|
Late expression of tumor necrosis factor-alpha is markedly depressed in patients with IgA nephropathy..
Immunological communications.
27:243-255.
1998
|
|
| 1998
|
Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis..
Journal of the American Society of Nephrology.
9:1104-1108.
1998
|
|
| 1998
|
Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994. Central Kentucky Region of the Southeastern United States IgA Nephropathy DATABANK Project..
Journal of the American Society of Nephrology.
9:853-858.
1998
|
|
| 1997
|
Renal transplantation in African-American recipients: three decades at a single center..
Transplantation Proceedings.
29:3726-3728.
1997
|
|
| 1997
|
The living donor process in kidney transplantation: influence of race and comorbidity..
Transplantation Proceedings.
29:3722-3723.
1997
|
|
| 1997
|
Angiotensin II stimulates proliferation of normal early erythroid progenitors..
Journal of Clinical Investigation.
100:2310-2314.
1997
|
|
| 1997
|
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG..
Kidney International.
52:509-516.
1997
|
|
| 1997
|
Human peritoneal B-1 cells and the influence of continuous ambulatory peritoneal dialysis on peritoneal and peripheral blood mononuclear cell (PBMC) composition and immunoglobulin levels..
Clinical and Experimental Immunology.
109:356-361.
1997
|
|
| 1997
|
The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients..
American Journal of Kidney Diseases.
29:608-614.
1997
|
|
| 1996
|
Benefits of continued cyclosporine through an indigent drug program..
American Journal of Kidney Diseases.
28:572-577.
1996
|
|
| 1996
|
Amlodipine increases cyclosporine levels in hypertensive renal transplant patients: results of a prospective study..
Journal of the American Society of Nephrology.
7:831-835.
1996
|
|
| 1996
|
Dilemmas in renal transplantation: when the clinical course and histological findings differ..
American Journal of Kidney Diseases.
27:435-440.
1996
|
|
| 1996
|
Impact of donor/recipient size matching on outcomes in renal transplantation..
Transplantation.
61:383-388.
1996
|
|
| 1996
|
Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy..
Kidney International.
49:571-577.
1996
|
|
| 1996
|
IgA nephropathy: Defect of glycosylation of IgA1 molecules.
Journal of Investigative Medicine.
44.
1996
|
|
| 1995
|
Complications of the musculoskeletal system in renal transplant recipients.
Journal of Nephrology.
8:231-237.
1995
|
|
| 1995
|
Progress in renal transplantation. A single center study of 3359 patients over 25 years..
Annals of Surgery.
221:446-457.
1995
|
|
| 1995
|
IgA nephropathy. A disease of incomplete IgA 1 glycosylation?.
Advances in Experimental Medicine and Biology.
376:221.
1995
|
|
| 1995
|
Intraperitoneal administration of tetanus toxoid elicits a specific response of antibody-secreting cells in the peritoneal cavity..
Advances in Experimental Medicine and Biology.
371A:103-106.
1995
|
|
| 1994
|
Hemolytically inactive C4B complement allotype caused by a proline to leucine mutation in the C5-binding site..
Journal of Biological Chemistry.
269:27727-27731.
1994
|
|
| 1994
|
Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis..
Kidney International.
46:1397-1403.
1994
|
|
| 1994
|
Posttransplant erythrocytosis: an enigma revisited..
American Journal of Kidney Diseases.
24:1-11.
1994
|
|
| 1994
|
Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response..
Clinical and Experimental Immunology.
96:356-363.
1994
|
|
| 1994
|
Immunological studies of IgA nephropathy in blacks reveal elevations of serum IgA2 as well as IgA1..
Nephrology Dialysis Transplantation.
9:1324-1329.
1994
|
|
| 1994
|
Renal retransplantation: the role of race, quadruple immunosuppression, and the flow cytometry cross-match..
Transplantation.
57:47-54.
1994
|
|
| 1993
|
Immunoglobulin A-fibronectin aggregate levels in children and adults with immunoglobulin A nephropathy..
American Journal of Kidney Diseases.
22:1-4.
1993
|
|
| 1993
|
Shared idiotypes in mesangial deposits in IgA nephropathy are not disease-specific..
Kidney International.
44:65-74.
1993
|
|
| 1993
|
Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center..
Annals of Surgery.
217:476-482.
1993
|
|
| 1993
|
Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients..
Journal of the American Society of Nephrology.
3:1570-1574.
1993
|
|
| 1993
|
Enalapril: safe and effective therapy for posttransplant erythrocytosis..
Transplantation Proceedings.
25:1029-1031.
1993
|
|
| 1993
|
Alternate-day prednisone therapy in IgA nephropathy. Preliminary analysis of a prospective, randomized, controlled trial..
Contributions to Nephrology.
104:198-206.
1993
|
|
| 1993
|
Bone loss after organ transplantation.
Transplantation reviews.
7:82-95.
1993
|
|
| 1993
|
Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy..
Contributions to Nephrology.
104:172-182.
1993
|
|
| 1993
|
Metabolic bone disease in renal transplant recipients.
Endocrinologist.
3:415-424.
1993
|
|
| 1993
|
Reply.
American Journal of Kidney Diseases.
21:344.
1993
|
|
| 1993
|
Tapering or discontinuing cyclosporine for financial reasons--a single-center experience..
American Journal of Kidney Diseases.
21:9-15.
1993
|
|
| 1992
|
Cytokine-induced immunoglobulin production in primary IgA nephropathy..
American Journal of Kidney Diseases.
20:611-617.
1992
|
|
| 1992
|
Binding of serum immunoglobulins to collagens in IgA nephropathy and HIV infection..
Kidney International.
42:374-382.
1992
|
|
| 1992
|
IgA-containing immune complexes after challenge with food antigens in patients with IgA nephropathy..
Clinical and Experimental Immunology.
89:315-320.
1992
|
|
| 1992
|
Benefits of quadruple immunosuppressive therapy in recipients of living related donor kidneys. A review of 855 operations..
Annals of Surgery.
215:606-616.
1992
|
|
| 1992
|
Familial IgA nephropathy associated with bilateral sensorineural deafness..
American Journal of Kidney Diseases.
19:592-596.
1992
|
|
| 1992
|
The impact of the UNOS mandatory sharing policy on recipients of the black and white races--experience at a single renal transplant center..
Transplantation.
53:770-774.
1992
|
|
| 1992
|
Musculoskeletal complications after renal transplantation: pathogenesis and treatment..
American Journal of Kidney Diseases.
19:99-120.
1992
|
|
| 1992
|
Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression..
Transplantation.
53:103-109.
1992
|
|
| 1992
|
Reply.
American Journal of Kidney Diseases.
20:531.
1992
|
|
| 1991
|
Effects of enalapril on erythrocytosis after renal transplantation..
Annals of Internal Medicine.
115:954-955.
1991
|
|
| 1991
|
Selective elevation of monomeric IgA1 in IgA nephropathy patients with normal renal function..
American Journal of Kidney Diseases.
18:313-319.
1991
|
|
| 1991
|
Rapid loss of vertebral mineral density after renal transplantation..
New England Journal of Medicine.
325:544-550.
1991
|
|
| 1991
|
C4A deficiency and poor prognosis in patients with IgA nephropathy..
Clinical Nephrology.
36:1-5.
1991
|
|
| 1991
|
IgA nephropathy in blacks: studies of IgA2 allotypes and clinical course..
Kidney International.
39:1218-1224.
1991
|
|
| 1991
|
Macroscopic hematuria and proteinuria preceding renal IgA deposition in patients with IgA nephropathy..
American Journal of Kidney Diseases.
17:472-479.
1991
|
|
| 1991
|
Are black living-related renal donors at greater long-term risk of renal complications than white donors?.
Transplantation Proceedings.
23:1328-1329.
1991
|
|
| 1991
|
Role for specific complement phenotypes and deficiencies in the clinical expression of IgA nephropathy..
American Journal of the Medical Sciences.
301:115-123.
1991
|
|
| 1991
|
Analysis of 22 years experience in living-related transplantation at the University of Alabama in Birmingham..
Clinical Transplants.
179-191.
1991
|
|
| 1991
|
Epstein-Barr virus transformation of B lymphocytes from IgA nephropathy patients and first-degree relatives results in increased immunoglobulin synthesis not restricted to IgA..
American Journal of Kidney Diseases.
17:55-61.
1991
|
|
| 1991
|
Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients..
Transplantation.
51:70-75.
1991
|
|
| 1991
|
OKT3 first-dose reaction: association with T cell subsets and cytokine release..
Kidney International.
39:141-148.
1991
|
|
| 1990
|
Cyclosporine-induced changes in glomerular filtration rate and urea excretion..
American Journal of Medicine.
88:497-502.
1990
|
|
| 1990
|
Regional variation in C4 phenotype in patients with IgA nephropathy..
Journal of Pediatrics.
116:S72-S77.
1990
|
|
| 1990
|
J. chain disease: a novel form of plasma cell dyscrasia..
American Journal of Medicine.
88:411-416.
1990
|
|
| 1990
|
C4B deficiency in two siblings with IgA nephropathy..
American Journal of Kidney Diseases.
15:66-71.
1990
|
|
| 1990
|
Cyclosporine-induced changes in glomerular filtration rate and urea excretion.
American Journal of Medicine.
88:503-511.
1990
|
|
| 1990
|
Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients..
Clinical Transplants.
289-300.
1990
|
|
| 1989
|
Successful renal allografts in recipients with a positive standard, DTE negative cross-match..
Transplantation Proceedings.
21:746-747.
1989
|
|
| 1989
|
Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera. Race, transplant history, and HLA-DR1 phenotype..
Transplantation.
47:240-245.
1989
|
|
| 1989
|
Sustained high panel reactive antibody levels in highly sensitized patients: significance of continued transfusions..
Transplantation Proceedings.
21:771-772.
1989
|
|
| 1989
|
NON-SPECIFIC MESANGIAL STAINING WITH ANTIBODIES AGAINST CYTOMEGALOVIRUS IN IMMUNOGLOBULIN-A NEPHROPATHY.
Lancet.
333:129-131.
1989
|
|
| 1989
|
Non-specific mesangial staining with antibodies against cytomegalovirus in immunoglobulin-A nephropathy..
Lancet.
1:129-131.
1989
|
|
| 1989
|
Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients..
Transplantation.
47:66-71.
1989
|
|
| 1988
|
Activation of complement in IgA nephropathy..
American Journal of Kidney Diseases.
12:437-442.
1988
|
|
| 1988
|
Familial clustering and immunogenetic aspects of IgA nephropathy..
American Journal of Kidney Diseases.
12:366-370.
1988
|
|
| 1988
|
Bilateral cavernous sinus thrombosis due to mucormycosis..
Archives of Ophthalmology -New Series-.
106:1089-1092.
1988
|
|
| 1988
|
On the mechanism by which chloride corrects metabolic alkalosis in man..
American Journal of Medicine.
84:449-458.
1988
|
|
| 1988
|
A comparison of OKT3 monoclonal antibody and corticosteroids in the treatment of acute renal allograft rejection..
American Journal of Kidney Diseases.
11:86-89.
1988
|
|
| 1988
|
Early graft loss in cyclosporine A-treated cadaveric renal allograft recipients receiving retransplants against previous mismatched HLA-A, -B, -DR donor antigens.
Transplantation Proceedings.
20:170-172.
1988
|
|
| 1988
|
IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?.
American Journal of Medicine.
84:129-132.
1988
|
|
| 1987
|
Analysis of immunoglobulin heavy chain restriction fragment length polymorphisms in IgA nephropathy..
Seminars in Nephrology.
7:306-310.
1987
|
|
| 1987
|
IgA-associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions..
Seminars in Nephrology.
7:332-335.
1987
|
|
| 1987
|
Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy..
Seminars in Nephrology.
7:389-392.
1987
|
|
| 1987
|
Aberrant synthesis of antibodies directed at the Fab fragment of IgA in patients with IgA nephropathies..
Clinical immunology and immunopathology.
45:208-213.
1987
|
|
| 1987
|
Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine..
Annals of Internal Medicine.
107:678-680.
1987
|
|
| 1987
|
Striking elevation of serum IgA, IgA-containing immune complexes, and IgA rheumatoid factor in clinically silent dermatitis herpetiformis..
American Journal of Kidney Diseases.
10:378-384.
1987
|
|
| 1987
|
A major gene model for the familial aggregation of plasma IgA concentration..
American Journal of Medical Genetics.
27:857-866.
1987
|
|
| 1987
|
Regionalization in hereditary IgA nephropathy..
American Journal of Human Genetics.
41:36-50.
1987
|
|
| 1987
|
Oxalosis in bone causing a radiographical mimicry of renal osteodystrophy..
American Journal of Kidney Diseases.
9:436-440.
1987
|
|
| 1987
|
Morphologic and immunohistochemical observations in granulomatous glomerulonephritis..
American Journal of Pathology.
126:581-591.
1987
|
|
| 1987
|
Antibodies directed at Fab of IgA in the sera of normal individuals and IgA nephropathy patients..
Advances in Experimental Medicine and Biology.
216B:1537-1544.
1987
|
|
| 1987
|
Complement activation in IgA nephropathy.
Kidney International.
31:1019-1023.
1987
|
|
| 1987
|
Complement phenotypes (C3 and C4) in IgA nephropathy..
Advances in Experimental Medicine and Biology.
216B:1569-1575.
1987
|
|
| 1987
|
Detection of food antigen-specific IgA immune complexes in human sera..
Advances in Experimental Medicine and Biology.
216A:813-820.
1987
|
|
| 1987
|
Genetic factors in primary IgA nephropathy..
Nephrology Dialysis Transplantation.
2:134-142.
1987
|
|
| 1987
|
Immunological studies of IgA nephropathy: familial and racial aspects..
Advances in Experimental Medicine and Biology.
216B:1489-1498.
1987
|
|
| 1987
|
Influence of race on renal allograft survival in the pre- and postcyclosporine era..
Clinical Transplants.
217-233.
1987
|
|
| 1986
|
Aluminum-associated renal osteodystrophy..
The Alabama journal of medical sciences.
23:414-419.
1986
|
|
| 1986
|
Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies..
Journal of Clinical Investigation.
77:1931-1938.
1986
|
|
| 1986
|
Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis..
American Journal of Nephrology.
6:275-283.
1986
|
|
| 1986
|
IgA-associated renal diseases: antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli..
Journal of Clinical Immunology.
6:74-86.
1986
|
|
| 1985
|
Familial IgA nephropathy..
New England Journal of Medicine.
313:186.
1985
|
|
| 1985
|
Focal sclerosis of hypertrophied glomeruli in solitary functioning kidneys of humans..
American Journal of Kidney Diseases.
5:226-232.
1985
|
|
| 1985
|
Familial IgA Nephropathy: Evidence of an Inherited Mechanism of Disease.
New England Journal of Medicine.
312:202-208.
1985
|
|
| 1985
|
The immunogenetics of IgA nephropathy.
Plasma Therapy and Transfusion Technology.
6:687-704.
1985
|
|
| 1984
|
Complement phenotypes in glomerulonephritis: increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpura..
Kidney International.
26:855-860.
1984
|
|
| 1984
|
IgA Nephropathy: Presentation, Clinical Course, and Prognosis in Children and Adults.
American Journal of Kidney Diseases.
4:192-200.
1984
|
|
| 1984
|
Increased frequency of C3 fast alleles in IgA nephropathy.
Disease Markers.
2:419-428.
1984
|
|
| 1983
|
Serum complement proteins in IgA nephropathy..
Clinical Nephrology.
20:251-258.
1983
|
|
| 1982
|
Renin and aldosterone responses to short-term NaCl or NaHCO3 loading in man..
Journal of Laboratory and Clinical Medicine.
100:261-268.
1982
|
|
| 1982
|
Partial H (beta 1H) deficiency and glomerulonephritis in two families..
Journal of Clinical Immunology.
2:110-117.
1982
|
|
| 1981
|
Properdin deficiency with IgA nephropathy..
New England Journal of Medicine.
305:1097.
1981
|
|
